Michael Hölzel

10.9k citations
143 papers · 8.4k · 5 hit papers · h-index 43

Impact in

  • Oncology top 1%
    • Cancer Immunotherapy and Biomarkers
    • Cancer Cells and Metastasis
  • Immunology top 1%
    • T-cell and B-cell Immunology
    • Immunotherapy and Immune Responses
    • Immune Cell Function and Interaction
    • Immune cells in cancer
    • IL-33, ST2, and ILC Pathways

Papers in

    • Cancer Immunotherapy and Biomarkers 37
    • Inflammatory Biomarkers in Disease Prognosis 6
    • Immunotherapy and Immune Responses 6

Michael Hölzel

138 papers receiving 8.3k citations

Michael Hölzel's Hit Papers

NECTIN4 Amplification Is Frequent in Solid Tumors and Predicts Enfortumab Vedotin Response in Metastatic Urothelial Cancer 2024 · 74 citations
740+4+8Years since publication100200300400500

Peers

Michael Hölzel
Comparison fields: 5 of 121
  • Oncology 2.7k
  • Immunology 1.8k
  • Physiology 282
  • Molecular Biology 2.2k
  • Cancer Research 429
Replace Veronika Sexl with:
Veronika Sexl Austria
Tobias Bald Germany
Thomas Tüting Germany
Bin Zhang United States
Stephen E. Fawell United States
Melissa R. Junttila United States
Russell William Jenkins United States
Anna M. Chytil United States
Jason D. Weber United States
Stephan N. Wagner Austria
Michael Hölzel relative to Veronika Sexl Austria Veronika Sexl's profile →
Citations per field
00.5×1.5×
Veronika Sexl · 1×
Citations per year

Countries citing papers authored by Michael Hölzel

Since Specialization
Citations

This map shows the geographic impact of Michael Hölzel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Hölzel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Hölzel more than expected).

Fields of papers citing papers by Michael Hölzel

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Hölzel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Hölzel. The network helps show where Michael Hölzel may publish in the future.

Co-authors

The 25 scholars most cited alongside Michael Hölzel, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Michael Hölzel Line = papers co-authored together Michael Hölzel links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 143 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Tumor immunoevasion by the conversion of effector NK cells into type 1 innate lymphoid cells
Hit paper breakdown →
2017556
2
Ultraviolet-radiation-induced inflammation promotes angiotropism and metastasis in melanoma
Hit paper breakdown →
2014527
3 2012505
4 2012371
5 2010368
6 2018317
7 2015297
8
Targeting CD39 in Cancer Reveals an Extracellular ATP- and Inflammasome-Driven Tumor Immunity
Hit paper breakdown →
2019234
9 2017230
10 2014229
11 2013227
12 2014217
13 2010175
14 2005164
15 2011162
16 2015162
17
Membranous NECTIN-4 Expression Frequently Decreases during Metastatic Spread of Urothelial Carcinoma and Is Associated with Enfortumab Vedotin Resistance
Hit paper breakdown →
2022157
18 2020137
19 2017136
20 2020128

About Michael Hölzel

Michael Hölzel is a scholar working on Oncology, Immunology, Molecular Biology, Pulmonary and Respiratory Medicine and Genetics, having authored 143 papers that have together received 8.4k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (37 papers), Bladder and Urothelial Cancer Treatments (11 papers), Melanoma and MAPK Pathways (10 papers), Renal cell carcinoma treatment (9 papers), Meningioma and schwannoma management (7 papers), Inflammatory Biomarkers in Disease Prognosis (6 papers), Nuclear Structure and Function (6 papers) and Immunotherapy and Immune Responses (6 papers). The work is most often cited by research in Oncology (2.7k citations), Immunology (1.8k citations), Physiology (282 citations), Molecular Biology (2.2k citations) and Cancer Research (429 citations). Michael Hölzel has collaborated with scholars based in Germany, United States and Australia. Frequent co-authors include Thomas Tüting, Dirk Eick, Tobias Bald, Jennifer Landsberg, Anton Bovier, Elisabeth Kremmer, Marcel Renn, Harasim Thomas, Rohrmoser Michaela and Malamoussi Anastassia. Their work appears in journals such as Immunity, Nature Communications, European Urology, Journal for ImmunoTherapy of Cancer and Cancers.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact